Table 1 Comparison between patients treated ≤ 6 months before vaccination and those treated > 6 months before vaccination regarding basic characteristics
Treated ≤ 6 months before vaccination (N = 36) | Treated > 6 months before vaccination (N = 84) | |||
|---|---|---|---|---|
Basic characteristics | No. | % | No. | % |
Sex | ||||
Male | 6 | 16.7 | 66 | 78.6 |
Female | 30 | 83.3 | 18 | 21.4 |
Age (years) | ||||
Mean±SD | 67.11 ± 4.86 | 47.77 ± 12.02 | ||
Median (range) | 66.50 | 45.50 | ||
Days between dose and PET-CT | ||||
Mean±SD | 11.91 ± 2.06 | 16.61 ± 3.61 | ||
Location | ||||
Axilla-level 1 | ||||
Absent | 31 | 86.1 | 28 | 33.3 |
Present | 5 | 13.9 | 56 | 66.7 |
Axilla-level 2 | ||||
Absent | 33 | 91.7 | 71 | 84.5 |
Present | 3 | 8.3 | 13 | 15.5 |
Axilla-level 3 | ||||
Absent | 35 | 97.2 | 75 | 89.3 |
Present | 1 | 2.8 | 9 | 10.7 |
Lower cervical | ||||
Absent | 35 | 97.2 | 79 | 94 |
Present | 1 | 2.8 | 5 | 6 |
Supraclavicular | ||||
Absent | 34 | 94.4 | 78 | 92.9 |
Present | 2 | 5.6 | 6 | 7.1 |
Days between PET-CT and serology | ||||
Mean±SD | 18.63 ± 0.83 | 17.01 ± 1.54 | ||
Median (range) | 18 (18–21) | 17 (15–21) | ||